SAN CLEMENTE, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and…
Proceeds will advance Cerevance’s potential first-in-class programs developed using proprietary NETSseq platform CVN424 for Parkinson’s disease will advance to Phase…
BILLERICA, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ: SQL and SQLLW) (“SeqLL” or the “Company”), a technology…
MINNEAPOLIS, Minn, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a clinical stage company developing disruptive…
Shareholder Meeting Follows the Company’s Successful Hearing with the Nasdaq Hearings PanelMIAMI, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Smart for…
- Q-Code assigned to CIMERLI® for Medicare claims processing effective for dates of service on and after April 1, 2023…
CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing…
-- Post hoc analyses found a statistically significant reduction in the duration of flu infection and a dose-related trend toward…
SAN DIEGO, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical…
New service gives customers even more choice with expanded ways to get started and manage aligner care in-person or remotelyNASHVILLE,…